Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Drug Hypersensitivity"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Management of Drug Hypersensitivity in Children
Condition: Drug Hypersensitivity
Intervention:
2 Recruiting Medical Device for Drug Allergy Diagnosis
Condition: Drug Hypersensitivity
Intervention: Procedure: Immediate hypersensitivity to BLC
3 Recruiting Optimal Doses for Drug Provocation Tests to Beta-lactams
Condition: Drug Hypersensitivity
Intervention: Procedure: simplified drug provocation test
4 Recruiting Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Condition: Drug Allergy
Intervention: Drug: Omalizumab
5 Recruiting Quality of Life of Patients With a History of Drug Allergy in Thailand
Condition: Quality of Life
Intervention: Other: Questionnaires
6 Recruiting Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment
Conditions: Mild Cognitive Impairment;   Herbal Medicine Allergy
Interventions: Drug: Qinggongshoutao Bolus;   Drug: Ginkgo Biloba Extract 761;   Drug: Placebos
7 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
8 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
9 Recruiting Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Conditions: Allergic Cutaneous Vasculitis;   Urticaria;   Psoriasis;   Acne;   Bullous Skin Diseases;   Sterile Pustulosis;   Leprosy;   Pneumocystis Pneumonia
Intervention: Drug: Dapsone
10 Recruiting MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY
Condition: Dermatitis, Adverse Drug Reaction
Interventions: Procedure: BALM ARM;   Procedure: PLACEBO ARM
11 Recruiting The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia
Condition: Palmar-Plantar Erythrodysesthesia
Interventions: Device: Vitamin B6 cream;   Device: Placebo Vitamin B6 cream
12 Recruiting Testing the Effectiveness of Henna on Managing PPE
Condition: Palmar-plantar Erythrodysesthesia (PPE)
Interventions: Drug: Henna;   Drug: Placebo
13 Not yet recruiting Role of Inflammatory Mediators in AERD
Condition: Asthma, Aspirin-Induced
Intervention: Drug: aspirin
14 Not yet recruiting Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
Condition: Hand Foot Syndrome
Interventions: Drug: Traditional Chinese Medicine Formula LC09;   Other: Placebo
15 Not yet recruiting Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Isotretinoin;   Other: Placebo
16 Recruiting G-CSF in the Treatment of Toxic Epidermal Necrolysis
Condition: Stevens - Johnson Syndrome
Interventions: Drug: recombinant granulocyte - colony stimulating factor;   Drug: NaCl 0.9%
17 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
18 Available Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Conditions: Limbal Stem Cell Deficiency;   Stevens-johnson Syndrome;   Ocular Cicatricial Pemphigoid;   Chemical Burn
Intervention: Biological: cultivated oral mucosal epithelial sheet transplantation
19 Recruiting High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Conditions: ASA Triad;   Asthma, Nasal Polyps, And Aspirin Intolerance
Intervention: Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
20 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.